Valuation Colinz Laboratories Limited

Stocks

Delayed Bombay S.E. Other stock markets 08:37:13 07/07/2026 +03			5-day change	1st Jan Change
70.00 ^INR	-4.99%		-15.95%	+30.52%

06-18	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI
06-18	Annjana Dugar, Likhitta Dugar and Antariksh Dugar proposed to acquire an additional 26% stake in Colinz Laboratories Limited for INR 35.4 million.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	40.82	34.74	107.6	160	94.59	182.5
Change	-	-14.89%	209.87%	48.62%	-40.87%	92.92%
Enterprise Value (EV) ¹	18.65	-2.149	60.43	105.4	30.29	133.4
Change	-	-111.53%	2,911.96%	74.47%	-71.27%	340.39%
P/E	31.3x	16.7x	31.8x	19.2x	19.5x	36.8x
PBR	0.6x	0.48x	1.4x	1.08x	1.06x	1.93x
PEG	-	0.3x	0.5x	0x	3.23x	17.76x
Capitalization / Revenue	0.54x	0.56x	1.54x	2.24x	1.35x	2.8x
EV / Revenue	0.25x	-0.03x	0.87x	1.47x	0.43x	2.04x
EV / EBITDA	6.16x	-0.65x	10.3x	16.7x	5.58x	26.9x
EV / EBIT	17.3x	-1.52x	15.7x	20.9x	7.34x	36.7x
EV / FCF	2.68x	-0.2x	8.87x	17.8x	4.12x	-7.62x
FCF Yield	37.3%	-506%	11.3%	5.62%	24.3%	-13.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.2854	0.4541	0.74	1.82	1.93	1.97
Distribution rate	-	-	-	-	-	-
Net sales ¹	76.03	61.59	69.74	71.55	70.3	65.28
EBITDA ¹	3.027	3.331	5.862	6.326	5.428	4.951
EBIT ¹	1.079	1.418	3.85	5.037	4.125	3.639
Net income ¹	1.304	2.076	3.393	4.574	4.867	4.966
Net Debt ¹	-22.17	-36.89	-47.22	-54.55	-64.3	-49.09
Reference price ²	8.93	7.60	23.55	35.00	37.55	72.44
Nbr of stocks (in thousands)	4,571	4,571	4,571	4,571	2,519	2,519
Announcement Date	9/2/20 A	8/30/21 A	8/24/22 A	8/29/23 A	8/29/24 A	8/28/25 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLINZ LABORATORIES LIMITED	-	-	-	-	1.95M
SUN PHARMACEUTICAL INDUSTRIES LTD.	39.45x	7.49x	25.55x	0.79%	48.11B
OTSUKA HOLDINGS CO., LTD.	19.42x	2.2x	10.38x	1.25%	37.88B
CIPLA LIMITED	28.35x	3.51x	17.98x	0.85%	12.47B
ZYDUS LIFESCIENCES LIMITED	25.17x	4.36x	16.23x	0.71%	12B
KRKA, D. D.	19.59x	3.38x	12.29x	3.48%	9.03B
GEDEON RICHTER	8.59x	2.03x	5.31x	5.05%	7.24B
ONO PHARMACEUTICAL CO., LTD.	16.35x	2.1x	7.08x	3.2%	7.09B
GLENMARK PHARMACEUTICALS LIMITED	34.47x	3.93x	16.72x	0.23%	6.72B
Average	23.92x	3.62x	13.94x	1.94%	15.62B
Weighted average by Cap.	27.58x	4.46x	16.74x	1.4%